Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • bioman1
    Member
    • May 2012
    • 80

    Making sense of low coverage plant genome

    In our lab we have de novo assembled non-model plant WGS ( 1 paired-end library - 2x101 bp) of insert size 240 bp, with N50 around 1 kbp. The estimated genome size is around
    2GB. Through read mapping we found coverage around 5x. I would like to get the idea to make possible of publication with this data.

    I have some idea in mind to make use of this low coverage genome

    1. Calling variant - finding SNP, heterozygosity & homozygosity (samtools, GATK)
    2. Finding microsatellites (MISA etc)
    3. Finding repeats using repeatmasker
    4. Extracting and assembling mitochondria and chloroplast genome

    Please add me if any ideas or related papers which can make of this low coverage genome.
  • scami
    Member
    • Sep 2010
    • 55

    #2
    Hi bioman1,

    if I were you I would proceed with annotation first, that is finding the coding sequences in your assembled genome. Number of found genes will give you an idea of how good is your assembly. On genes you can then run some gene ontology analysis.

    Comment

    • Brian Bushnell
      Super Moderator
      • Jan 2014
      • 2709

      #3
      It does not make a lot of sense to me to try to publish (or spend lots of time on) such a low-coverage assembly. It would be be much more cost-effective and useful to the rest of the world if you generated more coverage, and hence a better assembly, before going forward with further analysis.

      Comment

      • scami
        Member
        • Sep 2010
        • 55

        #4
        I agree with Brian actually. I would not trust snps and indels called with such a low coverage in the absence of a reference genome

        Comment

        • WhatsOEver
          Senior Member
          • Apr 2012
          • 215

          #5
          In your original post on the quality metrics of your assembly (http://seqanswers.com/forums/showthread.php?t=45673) we already discussed that your data is not good enough for publication. If the backbone of your analysis (i.e. the genome reference) is not in an adequate shape, how can any downstream analysis (#1-3) be?
          You might have sufficient coverage to assemble the mitochondria or chloroplast genome, but unless they are extremely unusual, I doubt that this alone will suffice for a publication.

          Comment

          • SNPsaurus
            Registered Vendor
            • May 2013
            • 525

            #6
            You would not be able to call heterozygosity with any accuracy. Think of a region with 5X read depth (your average). This means you are sampling the two chromosomes (if diploid) with 5 reads. What is the chance of not ever sampling one of the chromosomes? It would be 0.5^5 or 3%, or 6% chance of missing one or the other. You also couldn't call a SNP with just 1 read, and you would get 1X coverage of a chromosome 30% of the time.

            At 3X coverage you miss a chromosome 26% of the time, and the best case is that one chromosome gets 1 read and the other 2, so would never be able to call a SNP.
            Providing nextRAD genotyping and PacBio sequencing services. http://snpsaurus.com

            Comment

            • SES
              Senior Member
              • Mar 2010
              • 275

              #7
              Originally posted by bioman1 View Post
              The estimated genome size is around
              2GB. Through read mapping we found coverage around 5x.
              If you know the genome size, a more accurate estimate of coverage could be obtained by simply counting the total length of bases produced, rather than trying to infer this from mapping. This is really a minor point but it may make some difference.

              As others have said, anything close to 5X is way too low for producing an assembly but you still have plenty of data for exploring a number of interesting questions. For example, you have more than enough coverage for assembling the organelle genomes and for describing repeat properties in the genome (I can offer specific advice for each of these tasks if that is of interest).

              Comment

              • bioman1
                Member
                • May 2012
                • 80

                #8
                Thank you all for suggestiona. We have budget constraint, we can proceed gor further funding by making one publication with available data. Do I open to any kind of suggestind.
                SES please let me know your advice regarding organelle genome assembling and repeat properties identification.

                Comment

                • SES
                  Senior Member
                  • Mar 2010
                  • 275

                  #9
                  Originally posted by bioman1 View Post
                  Thank you all for suggestiona. We have budget constraint, we can proceed gor further funding by making one publication with available data. Do I open to any kind of suggestind.
                  SES please let me know your advice regarding organelle genome assembling and repeat properties identification.
                  I recommend trying Chloro for chloroplast genome assembly, and the same program can be used for mitochondrial genomes given a database (just a fasta file) of mitochondrial genomes to screen against. Transposome is a tool for identifying repeats from WGS reads, so the input would be your unassembled sequence reads. Please let me know if you have questions about either tool, perhaps via email or message would be more appropriate since this would be getting a bit off topic of this thread.

                  Comment

                  • bioman1
                    Member
                    • May 2012
                    • 80

                    #10
                    Thanks SES. I will try and I will contact you if any difficulties.

                    Comment

                    Latest Articles

                    Collapse

                    • SEQadmin2
                      Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
                      by SEQadmin2


                      Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

                      The systematic characterization of the human proteome has
                      ...
                      Today, 11:48 AM
                    • SEQadmin2
                      Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
                      by SEQadmin2



                      Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
                      ...
                      07-09-2026, 11:10 AM
                    • SEQadmin2
                      Cancer Drug Resistance: The Lingering Barrier to Rising Survival
                      by SEQadmin2



                      Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

                      There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
                      07-08-2026, 05:17 AM

                    ad_right_rmr

                    Collapse

                    News

                    Collapse

                    Topics Statistics Last Post
                    Started by SEQadmin2, Today, 11:10 AM
                    0 responses
                    8 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 07-13-2026, 10:26 AM
                    0 responses
                    30 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 07-09-2026, 10:04 AM
                    0 responses
                    39 views
                    0 reactions
                    Last Post SEQadmin2  
                    Started by SEQadmin2, 07-08-2026, 10:08 AM
                    0 responses
                    25 views
                    0 reactions
                    Last Post SEQadmin2  
                    Working...